ESR1 and lung adenocarcinoma: LINC01297 is upregulated in estrogen receptor (ER)-positive breast cancer, in comparison with ER-negative breast cancer [60] and lung adenocarcinoma [61]; there is also a positive correlation between LINC01297 and the expression of its nearby gene LINC01296, which acts as an oncogene in bladder cancer [62].